ANSM Orders Halt of Vaccine Production At Theravectys Over GMP Lapses

International Pharmaceutical Regulatory Monitor
A A
France’s National Agency for Medicines and Health Products Safety has ordered vaccine maker Theravectys to halt production at its Villejuif plant for seven months after finding numerous GMP deficiencies.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor